A groundbreaking development in diabetes management may soon provide needle-averse patients with a painless alternative to ...

A 10-year-old girl with Type 1 diabetes died after slipping into a coma while on a road trip with her family over the summer, ...

A new polymer reported in Nature may mark a turning point for needle-free insulin delivery. Researchers at Zhejiang University have developed a charge-shifting polyzwitterion that can carry insulin ...

In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...

Insulet also expects in 2028 to release the Omnipod Fully Closed Loop for Type 2, which will automate insulin delivery for patients with type 2 diabetes. It said the out-of-the-box product will be the ...

Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.

Shares of Insulet Corporation (PODD) slipped ~7% on Thursday as the insulin pump maker announced its long-term financial outlook during its 2025 Investor Day at the company’s headquarters in Acton, ...

Insulet (Nasdaq:PODD) today hosted its Investor Day event, led by CEO Ashley McEvoy, laying out the future for the insulin ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Shares of Insulet Corporation (PODD) traded higher on Wednesday after UBS upgraded the insulin pump maker to Buy from Neutral just ahead of its Investor Day on Nov. 20, citing the company’s growth ...

Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance.